Tagged: neurometrix

June 15, 2015 @ 9:27 am By Samantha Hurst  |  

NeuroMetrix, Inc. (NASDAQ:NURO) announced the full commercial launch of Quell, which is now available on the its product website at QuellRelief.com and at select physicians’ offices. Earlier this year, the device had debuted through a pre-order campaign on Indiegogo and met its $100,000 goal in less than two days. It achieved… Read More

May 14, 2015 @ 11:46 am By Samantha Hurst  |  

NeuroMetrix, Inc. (Nasdaq: NURO) reported it has started shipping Quell wearable pain relief devices out of its production and fulfillment facility in Woburn, MA. The initial shipments are directed to leading doctors and thought leaders in chronic pain. The company anticipates that it will start fulfilling… Read More

March 4, 2015 @ 10:38 am By Samantha Hurst  |  

NeuroMetrix, Inc. (Nasdaq: NURO) announced that on the day after launching its crowdfunding campaign on Indiegogo, its product Quell has exceeded the $100,000 initial goal. The company reported preorders for over 500 Quell devices. Demand exceeded company projections and the initial offer sold out in less than 6-hours. The… Read More

March 2, 2015 @ 9:28 am By Samantha Hurst  |  

On Monday (March 2nd), NeuroMetrix, Inc. (Nasdaq: NURO) announced the launch of its campaign on global crowdfunding platform, Indiegogo for a new wearable pain relief product, Quell. Frank McGillin, SVP and General Manager of Consumer Health at NeuroMetrix explained the campaign objective: “We are new to… Read More